- Report
- February 2026
- 250 Pages
Global
From €4047EUR$4,490USD£3,477GBP
- Report
- September 2026
- 300 Pages
Global
From €5273EUR$5,850USD£4,531GBP
- Report
- May 2026
- 30 Pages
Global
From €2479EUR$2,750USD£2,130GBP
- Report
- July 2026
- 113 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- May 2026
- 100 Pages
Global
From €2433EUR$2,699USD£2,090GBP
- Report
- May 2026
- 150 Pages
Global
From €2433EUR$2,699USD£2,090GBP
- Report
- May 2026
- 150 Pages
Global
From €2433EUR$2,699USD£2,090GBP
- Report
- May 2026
- 150 Pages
Global
From €2433EUR$2,699USD£2,090GBP
- Report
- May 2026
- 100 Pages
Global
From €2433EUR$2,699USD£2,090GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2514EUR$2,789USD£2,160GBP
- Report
- March 2026
- 150 Pages
Global
From €2433EUR$2,699USD£2,090GBP
- Report
- April 2026
- 137 Pages
Global
From €2703EUR$2,999USD£2,323GBP
€3605EUR$3,999USD£3,097GBP
- Report
- July 2026
- 120 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- July 2026
- 130 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- July 2026
- 112 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- June 2026
- 150 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- June 2026
- 150 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- February 2026
- 200 Pages
Global
From €4503EUR$4,995USD£3,869GBP
- Report
- July 2026
- 160 Pages
Global
From €2993EUR$3,320USD£2,571GBP
€3741EUR$4,150USD£3,214GBP
- Report
- June 2026
- 160 Pages
Global
From €2523EUR$2,799USD£2,168GBP
€3154EUR$3,499USD£2,710GBP

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more